Kessia Maira Da Silva Bueno Died of Sinovac

2 years ago
363

Kessia Maira Da Silva Bueno
Sinovac-CoronaVac
First 25th Jan 2021
Second 18th February 2021
Died 27th April 2021 - Immediate Adverse Reaction: Stroke, Acute liver failure, Leukaemia

My name is Amalia. Since my daughter Késsia, a healthy 27-year-old. Received the first dose of the Coronavac vaccine, on 25th Jan 2021, she began to have a lot of chest pain. She was a healthcare professional, and when she received the second dose of the Coronavac vaccine on 18th February 2021 batch: 207010020, she began to experience even more chest pain, numbness in one of her hands and blurred vision.

Soon, she sought medical attention and was diagnosed with anaemia and psychological problems due to being away from home. As the days went by, the chest pains only got worse and she had to return home to Dom Pedrito/RS, as she was no longer able to work.

When we got home, we redid the blood tests and found anaemia. In the comings and goings of consultations, she was diagnosed with Covid-19. The doctor opted for hospitalization, and blood transfusion because it was necessary. After a few days she was discharged, but at home she did not have much improvement, reporting headaches, blurred vision and numbness in one of her hands and vomiting. They did some tests, which found liver and kidney problems, and the doctor advised immediate hospitalization.

Arriving at the emergency room, she underwent a CT scan where liver problems were found. A new blood count was performed, which was totally altered. They set up a medical board and called me, they decided that she would be transferred to a bigger centre, because they didn't know what she had. My daughter had a stroke before being transferred.

Arrived in Porto Alegre 27th April 2021 at 4:30 am, and around 8:00 am she was intubated. Shee passed away on Friday, 30th April 2021. The Certificate of Death includes stroke, acute and sub-acute liver failure, sub-acute leukaemia of unspecified cell type.”

Dom Pedrit, Brazil

Loading 3 comments...